Global WholeHealth Partners Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GWHP research report →
Companygwhpcorp.com
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases.
- CEO
- Edgar B. Gonzalez
- IPO
- 2015
- HQ
- San Clemente, CA, US
Price Chart
Valuation
- Market Cap
- $1.31K
- P/E
- -0.00
- P/S
- 0.18
- P/B
- -0.00
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -1518.64%
- Op Margin
- -56759.32%
- Net Margin
- -69898.31%
- ROE
- 618.63%
- ROIC
- 477.11%
Growth & Income
- Revenue
- $7.38K · -81.65%
- Net Income
- $-5,155,000 · 42.94%
- EPS
- $-0.05 · 60.79%
- Op Income
- $-4,186,000
- FCF YoY
- -204.53%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -11.47
- Avg Volume
- 6
Get TickerSpark's AI analysis on GWHP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GWHP Coverage
We haven't published any research on GWHP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GWHP Report →